COMMUNIQUÉS West-GlobeNewswire

Medtronic Chairman and CEO Omar Ishrak to Speak at Morgan Stanley Global Healthcare Conference
07/09/2017
DUBLIN - September 7, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 15th Annual Morgan Stanley Global Healthcare Conference on Monday, [...]
Arix Bioscience plc notes positive trial data from Verona Pharma in COPD
07/09/2017
Arix Bioscience plc notes positive trial data from Verona Pharma in COPD LONDON, 7 September 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience"), a global healthcare and life science company supporting medical [...]
Nuvaira Announces Four Clinical Abstracts Accepted for Presentation at ERS International Congress
07/09/2017
Treating COPD and Asthma with Targeted Lung Denervation is Focus of Mini-Symposium MILAN, Italy, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Nuvaira , a developer of medical devices to treat obstructive lung diseases, today [...]
XBiotech Announces Presentation of Phase 2 Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa
07/09/2017
Results of the Randomized Phase 2 Study Evaluating MABp1 for the Treatment of Hidradenitis Suppurati AUSTIN, Texas, Sept. 07, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that results from the [...]
Nuvaira annonce la sélection de quatre rapports cliniques pour présentation lors du Congrès international de la SRE
07/09/2017
Le traitement des maladies pulmonaires obstructives chroniques (MPOC) et de l'asthme par dénervation pulmonaire ciblée fera l'objet d'un mini-colloque MILAN, Italie, le 7 septembre 2017 (GLOBE NEWSWIRE) - Nuvaira , un [...]
GSK Exercises Option over SPEAR T-cell Therapy Program Targeting NY-ESO
07/09/2017
PHILADELPHIA and OXFORD, United Kingdom, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that GlaxoSmithKline plc (LSE:GSK) ( [...]
Sanofi Alliance Partner Alnylam Gives Update on Fitusiran
07/09/2017
Sanofi Alliance Partner Alnylam Provides Update on Fitusiran Development Program Paris, France - September 7, 2017 - Sanofi alliance partner Alnylam Pharmaceuticals today provided an update on the clinical development [...]
Le partenaire de Sanofi, Alnylam, fait le point sur le programme de développement du fitusiran
07/09/2017
Le partenaire de Sanofi, Alnylam, fait le point sur le programme de développement du fitusiran Paris, France - Le 7 septembre 2017 - Le partenaire de Sanofi , Alnylam Pharmaceuticals, a fait le point aujourd'hui sur le [...]
Medtronic Recognized for Its Sustainability Leadership
07/09/2017
Company Marks a Decade on the North American Dow Jones Sustainability Index (DJSI) DUBLIN - September 7, 2017 - Medtronic plc (NYSE: MDT) was recognized today as one of the world's leading companies for sustainability [...]
Shire to participate at two upcoming investor conferences
07/09/2017
Shire to participate at two upcoming investor conferences Lexington, MA, USA - September 7, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Flemming Ornskov, MD, Chief Executive Officer, will present at the [...]
Zealand and Orbit Discovery enter into research collaboration
07/09/2017
Company announcement - No. 45 / 2017 Zealand and Orbit Discovery enter into research collaboration Combining Zealand's expertise in discovery and development of peptide therapeutics with Orbit's unique peptide libraries [...]
Helsinn Group supports prIME's Satellite Symposium at ESMO 2017
07/09/2017
Helsinn Group supports prIME's Satellite Symposium at ESMO 2017 World-renowned supportive care experts in oncology explore how to provide the best care for patients by incorporating patient-reported outcomes into the [...]
Verona Pharma Announces Positive Top-Line Data from Phase 2a Clinical Trial in COPD with RPL554 Dosed in Addition to Tiotropium (Spiriva®)
07/09/2017
Achieved significant and clinically meaningful additional improvement in peak lung function and faster onset-of-action when added to tiotropium Demonstrated statistical significance across all primary and secondary [...]
Sanofi rated AA by Scope Ratings
07/09/2017
Sanofi rated AA by Scope Ratings Paris, France - September 7, 2017 - Sanofi announced today that the European ratings agency Scope Ratings AG ("Scope") assigned the company a AA long term rating and a S-1+ short-term [...]
Sanofi noté AA par Scope Ratings
07/09/2017
Sanofi noté AA par Scope Ratings Paris, France - Le 7 septembre 2017 - Sanofi annonce aujourd'hui que l'agence européenne de notation de crédit Scope Ratings AG ("Scope") lui a attribué une notation de long-terme AA et [...]
Biocartis Group NV: Biocartis announces H1 2017 results
07/09/2017
PRESS RELEASE: REGULATED INFORMATION Thursday, 7 September 2017, 07:00 CEST BIOCARTIS ANNOUNCES H1 2017 RESULTS Mechelen, Belgium , 7 September 2017 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative [...]
ABLYNX TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN LONDON
07/09/2017
GHENT, Belgium, 7 September 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announces that it will participate in the following upcoming investor conferences taking place in London, UK: J.P. Morgan's London [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 31 août 2017
06/09/2017
Nombre total de droits de vote et d'actions composant le capital social au 31 août 2017 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France ( [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2017
06/09/2017
Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2017 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]

Pages